Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-16

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)

View source ↗

Summary

FDA approved a supplemental application for Apnar Pharma LP's generic Bupropion hydrochloride, confirming approval to market the product with the same indicatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)